LONDON — European stocks pulled back on Tuesday on new fears around the omicron Covid variant and vaccines.
The pan-European Stoxx 600 fell 1.4% in early trade, with oil and gas stocks dropping 2.9% to lead losses as all sectors and major bourses slid into negative territory.
U.S. stock futures also sharply reversed course after rising in overnight trading, while Asia-Pacific markets were mostly lower by Tuesday's close as investors reassessed the risks associated with the new variant.
The reversal came after Moderna CEO Stephane Bancel told the Financial Times that he expects existing vaccines to be less effective against the new variant. Bancel told CNBC on Monday that it could take months to develop and ship an omicron-specific vaccine.
He expressed some uncertainty about omicron, saying that will take at least two weeks to determine how much the mutations have affected the efficacy of the vaccines currently on the market.
"Depending on how much it dropped, we might decide on the one hand to give a higher dose of the current vaccine around the world to protect people. Maybe people at very high risk, the immunocompromised, and the elderly should need a fourth dose," he said.
Monday's rebound
European and U.S. stocks had begun a tentative rebound on Monday following last Friday's sell-off as concerns over the newly discovered omicron Covid variant appeared to ease.
In the U.S., stocks got a big boost after U.S. President Joe Biden said lockdowns in response to the omicron variant are currently off the table and there will be no new travel restrictions.
Covid symptoms linked to the omicron variant have been described as "extremely mild" by the South African doctor who first spotted the new strain. Nonetheless, the World Health Organization warned Monday that the omicron variant is likely to spread further and poses a "very high" global risk.
Economic data
Data released Tuesday showed Chinese factory activity unexpectedly growing in November, with China's official manufacturing Purchasing Managers' Index for November coming in at 50.1. That was above expectations by analysts in a Reuters poll for a reading of 49.6. PMI readings below 50 represent contraction while those above that level signify expansion.
Stateside, investors are looking ahead to key economic data set to be released this week, including the November jobs report on Friday which is expected to show solid jobs growth. Economists surveyed by Dow Jones expect 581,000 jobs to have been added in November.
Earnings on Tuesday came from Easyjet, Greencore, SAS and Volvo Cars on Tuesday while data releases include flash inflation figures for the euro zone in November.
France's final third-quarter gross domestic product growth was confirmed at 3% quarter on quarter, while inflation rose to an annual rate of 3.4% in November, its highest since September 2008.
In terms of individual share price movement, British media company Future surged more than 15% in early trade after producing a strong earnings report and raising its full-year outlook for 2022.
At the bottom of the European blue chip index, Sweden's Lundin Energy fell more than 11%, giving back most of Monday's gains that came after Bloomberg reported that that the oil and gas company is considering a sale or merger.
Enjoyed this article?
For exclusive stock picks, investment ideas and CNBC global livestream
Sign up for CNBC Pro
Start your free trial now
— CNBC's Eustance Huang and Spencer Kimball contributed to this market report.
"open" - Google News
November 30, 2021 at 12:22PM
https://ift.tt/3rhOGUh
European stocks fall amid omicron vaccine fears; Stoxx 600 down 1.4% - CNBC
"open" - Google News
https://ift.tt/3bYShMr
https://ift.tt/3d2SYUY
Bagikan Berita Ini
0 Response to "European stocks fall amid omicron vaccine fears; Stoxx 600 down 1.4% - CNBC"
Post a Comment